http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105324115-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c27bd181389e18a141b5ff01b663b838
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-397
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-397
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
filingDate 2014-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31004c6ed30e546d2082b43760e4cd34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e4a9d1780e77a0c751ff70aa37fcf85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee096265ae401b024265642563cee904
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d6b0af21d36f34c7524e8f524d6d584
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e8d87e755d39888b02cb74e262cc551
publicationDate 2016-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105324115-A
titleOfInvention Estrogen receptor modulators and uses thereof
abstract This application describes compounds that are modulators of the estrogen receptor. The application also describes pharmaceutical compositions and medicaments comprising the compounds described herein, and the use of said estrogen receptor modulators alone and in combination with other compounds for the treatment of estrogen receptor mediated or dependent The method of a disease or condition.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107406433-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110343101-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110343101-B
priorityDate 2013-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102939287-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6262270-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5407947-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004091488-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87055263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430849687
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465007774

Total number of triples: 42.